Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net loss	$ (4,310,998)	$ (3,143,601)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	9,715	8,737
Share-based compensation	57,521	346,548
Straight-line rent expense	(2,069)	(2,068)
Change in fair value of derivative liabilities	(367,277)	451,054
Non-cash interest expense on notes payable and consideration payable	671,578
R&D costs for intangible assets	61,019
Changes in operating assets and liabilities:
Receivables	8,266	4,507
Prepaid expenses and deposits	283,722	(138,636)
Inventory	(490,754)	(269,164)
Accounts payable and accrued liabilities	383,119	449,281
Customer deposits	2,890	44,681
Due to related parties	206,833	80,000
Cash flows used in operating activities	(3,486,435)	(2,168,661)
Investing activities
Purchase of equipment	(9,160)	(11,191)
Purchase of intangible assets	(162,320)
Cash flows used in investing activities	(171,480)	(11,191)
Financing activities
Net proceeds from issuance of common stock and warrants	6,993,059	1,463,586
Net proceeds from issuance of Notes	914,442
Repayment of Notes	(1,150,000)
Exercise of stock options		37,500
Cash flows provided by financing activities	6,757,501	1,501,086
Effect of exchange rate changes on cash	(767)	720
Increase (decrease) in cash	3,098,819	(678,046)
Cash, beginning of period	3,326,851	1,154,901
Cash, ending of period	6,425,670	476,855
Supplemental cash flow information:
Cash paid for interest	23,248	4,898
Cash paid for taxes
Non-cash Investing and Financing transactions:
Common stock issued and issuable on acquisition of intangible asset	$ 1,610,778